These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 7670175

  • 1. Role of liver transplantation in patients with hepatitis B infection.
    Holt CD, Millis JM, Busuttil RW.
    Clin Transplant; 1995 Jun; 9(3 Pt 2):269-76. PubMed ID: 7670175
    [Abstract] [Full Text] [Related]

  • 2. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M, Sherker A, Sinclair SB, Greig PD, Cameron R, Phillips MJ, Blendis L, Chung SW, Levy GA.
    Transplantation; 1994 Jul 27; 58(2):183-92. PubMed ID: 8042236
    [Abstract] [Full Text] [Related]

  • 3. Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus.
    Marsman WA, Wiesner RH, Batts KP, Poterucha JJ, Porayko MK, Niesters HG, Zondervan PE, Krom RA.
    Hepatology; 1997 Feb 27; 25(2):434-8. PubMed ID: 9021960
    [Abstract] [Full Text] [Related]

  • 4. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients].
    Yang Y, Yang Y, Zhang J, Yi HM, Lu MQ, Cai CJ, Li X, Jiang N, Xu C, Li H, Wang GS, Yi SH, Zhang JF, Jiang H, Yang Q, Chen GH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct 27; 28(10):1810-2. PubMed ID: 18971179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of liver transplantation in viral hepatitis.
    Pons JA.
    J Hepatol; 1995 Oct 27; 22(1 Suppl):146-53. PubMed ID: 7602069
    [Abstract] [Full Text] [Related]

  • 7. Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation.
    Ben-Ari Z, Mor E, Shapira Z, Tur-Kaspa R.
    Liver Transpl; 2001 Feb 27; 7(2):113-7. PubMed ID: 11172394
    [Abstract] [Full Text] [Related]

  • 8. Should liver transplantation be performed for patients with hepatitis B?
    Eason JD, Freeman RB, Rohrer RJ, Lewis WD, Jenkins R, Dienstag J, Cosimi AB.
    Transplantation; 1994 Jun 15; 57(11):1588-93. PubMed ID: 8009592
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L, Vargas V, Rodríguez F, Allende H, Buti M, Sánchez-Avila JF, Jardí R, Margarit C, Pumarola T, Esteban R, Guardia J.
    Liver Transpl; 2002 Oct 15; 8(10):892-900. PubMed ID: 12360430
    [Abstract] [Full Text] [Related]

  • 10. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
    Roche B, Samuel D, Feray C, Majno P, Gigou M, Reynes M, Bismuth H.
    Liver Transpl Surg; 1999 May 15; 5(3):166-74. PubMed ID: 10226106
    [Abstract] [Full Text] [Related]

  • 11. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH.
    Hepatobiliary Pancreat Dis Int; 2004 Feb 15; 3(1):26-32. PubMed ID: 14969833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM, Fang GX, Tang CS, Cheng IK, Lai KN, Ho SK.
    Hepatology; 2002 Nov 15; 36(5):1246-52. PubMed ID: 12395336
    [Abstract] [Full Text] [Related]

  • 15. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
    Rambusch EG, Nashan B, Tillmann HL, Böker KH, Schlitt HJ, Maschek H, Raab R, Manns MP.
    Z Gastroenterol; 1998 Dec 15; 36(12):1027-35. PubMed ID: 10025054
    [Abstract] [Full Text] [Related]

  • 16. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb 15; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of hepatitis B virus recurrence after liver transplantation.
    Han YS, Lee SK, Joh JW, Kim SJ, Kwon CH, Park JW, Kim DJ, Park JB.
    Transplant Proc; 2006 Sep 15; 38(7):2123-4. PubMed ID: 16980019
    [Abstract] [Full Text] [Related]

  • 18. Pretransplantation pre-S2 and S protein heterogeneity predisposes to hepatitis B virus recurrence after liver transplantation.
    Grottola A, Buttafoco P, Del Buono MG, Cremonini C, Colantoni A, Gelmini R, Morelli C, Masetti M, Jovine E, Fruet F, Pinna A, Manenti F, Villa E.
    Liver Transpl; 2002 May 15; 8(5):443-8. PubMed ID: 12004344
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA, Buffello-Le Guillou D, Roche B, Dussaix E, Duclos-Vallée JC, Féray C, Samuel D.
    J Med Virol; 2001 Nov 15; 65(3):493-504. PubMed ID: 11596084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.